• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Andra medicinska specialiteter
    3. Neurologi och klinisk neurofysiologi

    Pharmacological Foundations of Parkinson's Disease

    From Mechanisms to Clinical Practice

    AvWael Mohamed

    Häftad, Engelska, 2026

    1 773 kr

    Kommande

    Beskrivning

    Pharmacological Foundations of Parkinson's Disease: From Mechanisms to Clinical Practice provides a comprehensive guide on the pharmacological treatment of Parkinson's Disease, offering students and clinicians a combination of foundational knowledge and advanced clinical insights. The book bridges theoretical concepts with real-world clinical scenarios and equips readers with the tools necessary to effectively manage Parkinson's Disease in practice. Offering a detailed review of symptoms, treatment gaps, and emerging therapies, this book delves into the pathogenesis the disease, along with dopaminergic treatments and management of motor and non-motor symptoms.

    Providing updates on emerging therapies, including innovative treatment approaches, this book serves as a valuable reference for continuous learning and staying current with evolving practices and research in Parkinson's Disease management.

    • Reviews current pharmacological treatments for Parkinson's Disease, from foundational principles to advanced applications
    • Outlines the latest treatment protocols, therapeutic strategies, and emerging trends in Parkinson’s Disease pharmacotherapy
    • Provides detailed insights into how different drugs operate at the molecular and cellular levels, enhancing comprehension of PD pathophysiology and drug mechanisms
    • Presents case studies, clinical trial outcomes, and real-world applications, detailing practical insights applicable to both research and clinical practice

    Produktinformation

    • Utgivningsdatum:2026-09-01
    • Mått:191 x 235 x undefined mm
    • Vikt:450 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:350
    • Förlag:Elsevier Science
    • ISBN:9780443277023

    Utforska kategorier

    • Neurologi och klinisk neurofysiologi inom Medicin
    • Farmakologi inom Medicin

    Mer om författaren

    Dr. Wael Mohamed, BSc, MMSc, MD, PhD, FAAS, is Professor, Basic Medical Science Department at the International Islamic University Malaysia (IIUM). He specializes in translational brain research and the development of novel treatments for Alzheimer’s Disease and Parkinson’s Disease.

    Innehållsförteckning

    • Section I: Introduction1. Parkinson’s Disease Pathogenesis: From Molecular Insights to Novel Therapies2. Cultural and Regional Considerations in Parkinson’s Pharmacotherapy3. The Tango of Parkinson’s Treatment: The Dance of Balance and Harmony4. Environmental Neurotoxins, Circadian Rhythms and Their Pharmacological Antagonists in Parkinson’s Disease5. Oral Bacteriome Dysbiosis and Mechanisms in Cognitive Impairment among Older People and Parkinson’s Disease: A Systematic ReviewSection II: L-DOPA and DOPAMINERGIC AGENTS6. Dopaminergic Treatments for Parkinson’s Disease: Seeing the Unseen7. Catechol-O-Methyl-Transferase (COMT) Inhibitors: Present Problems and Relevance of the New Ones8. D3 Receptor Agonists and Antagonists as Anti-Parkinsonian Therapeutic Agents9. Non-Dopaminergic TherapiesSection III: EMERGING DRUGS AND TARGETS FOR PARKINSON'S DISEASE10. Management of Motor Symptoms11. Non-Motor Symptoms and Their Pharmacological Management12. Pharmacokinetics and Pharmacodynamics in Parkinson's Disease13. Clinical Case Studies and Practical Applications14. Epigenetic Modulators: Emerging Players in Parkinson’s PharmacotherapySection IV: FUTURE THERAPEUTIC POSSIBILITIES15. Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease16. Future Directions in Parkinson's Disease Pharmacotherapy17. Pioneering The Next Generation Of Therapies18. Genetic Therapies for Parkinson’s Disease: The Dawn of Precision Medicine19. The Gastrointestinal Microbiota and Parkinson’s Disease: What is known and what is still unknown.20. Artificial Intelligence and Machine Learning in Parkinson’s Drug Development21. Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunct to Pharmacotherapy in Parkinson’s DiseaseSection V: PHARMACOTHERAPY: HOPES AND HYPES22. Neuroprotective Therapies in Parkinson's Disease23. Polypharmacy and combination therapies in Parkinson’s Disease24. Repurposing Existing Drugs for Parkinson’s Disease Management25. Personalized Medicine andin Parkinson's Disease: Bridging Research and Practice26. Neuroprotective Diets and Their Synergy with PD Pharmacotherapy27. Natural products in the management of Parkinson’s disease in animal modelsSection VI: COGNITIVE NEHANCERS AND PD PHARMACOTHERAPY28. Cognitive Enhancers in Parkinson’s Disease29. Emerging Targets for Cognitive Enhancement30. Artificial Intelligence in PD Pharmacotherapy / Neurostimulation and AI-Augmented Cognitive Therapy31. Personalized Medicine for Cognitive Impairments in PD32. Ethical and Practical Challenges with Cognitive Enhancers33. Unani Pharmacotherapy in the Management of Parkinson’s disease: A Therapeutic Approach34. Music therapy and its synergy with pharmacotherapy in Parkinson’s Disease35. Summary and Conclusion